In vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the Translational Pipeline? (2021)
Attributed to:
EnCRISPrx - A Permanent CRISPR-based Approach To Rescue Dravet Syndrome By Enhancing Scn1a Promoter Activity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fnins.2021.632522
PubMed Identifier: 33679313
Publication URI: http://europepmc.org/abstract/MED/33679313
Type: Journal Article/Review
Volume: 15
Parent Publication: Frontiers in neuroscience
ISSN: 1662-453X